Open AccessInvestigating the impact of silymarin on liver oxidative injury
Author(s) -
Mohammad Jamalian,
Behnam Mahmodiyeh,
Sahar Saveiee,
Hassan Solhi
Publication year - 2020
Publication title -
journal of family medicine and primary care
Language(s) - English
Resource type - Journals
eISSN - 2278-7135
pISSN - 2249-4863
DOI - 10.4103/jfmpc.jfmpc_929_19
Subject(s) - medicine , alanine transaminase , aspartate transaminase , prothrombin time , transaminase , liver injury , gastroenterology , placebo , hypoxia (environmental) , white blood cell , leukocytosis , pharmacology , elevated transaminases , partial thromboplastin time , liver enzyme , alanine aminotransferase , creatine kinase , enzyme , coagulation , pathology , biochemistry , alkaline phosphatase , chemistry , alternative medicine , organic chemistry , oxygen
Various drugs affect liver problems caused by general hypoxia, including silymarin. Due to the fungal killer toxins, nowadays, silymarin (milk thistle) is used as an effective drug in the prevention and treatment of liver diseases and liver toxicity. In addition, silymarin protects the liver cells from solvents and chemical substances. The aim of this paper is to investigate the impact of silymarin on liver problems induced by general hypoxia.